The suppressor of cytokine signaling-3 (SOCS3) is an inducible negative regulator of the JAK/STAT pathway, implicated in various inflammatory diseases. In this study, we investigated the role of SOCS3 ...

ORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of ...

Filled with the top stories to start your day, and emergency news alerts.

Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help ...

The survey, obtained by STAT, is titled “Foreign Assistance Review,” and appears to be in response to an Office of Management and Budget directive aimed at complying with President Trump’s ...

Women are reshaping logistics, yet barriers remain. How is the industry evolving to foster inclusivity and leadership?

2. AHEAD项目在2024年美国皮肤科学会年会发布最新中期分析结果，显示阿布昔替尼在18岁及以上中重度AD患者中展现出快速、持续的疗效。

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...